shutterstock_1086968018_jarretera-2
Jarretera / Shutterstock.com
1 October 2019Big PharmaSaman Javed

FDA and DEA warn over sale of misbranded opioid drugs

The US Food and Drug Administration ( FDA) and Drug Enforcement Administration ( DEA) have issued joint warning letters to four online networks which allegedly sell unapproved and misbranded versions of medicines.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
30 August 2018   The US Food and Drug Administration has warned 21 websites over the illegal marketing of misbranded versions of opioid medications.